Sartorius Stedim Biotech (FR:DIM) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sartorius Stedim Biotech has released its first-half 2024 financial results and provides forecasts for the rest of the year. The internationally active biopharmaceutical partner reported a turnover of approximately 2.8 billion euros in 2023 and employs around 10,600 people globally. The full investor news is available on the company’s website.
For further insights into FR:DIM stock, check out TipRanks’ Stock Analysis page.